Elens, L.

cyp 3a cyp 3a activity patient cyp 3a allele allele simvastatin study activity genotype effect cyp 3a carriers carrier midazolam cancer intron cyp 3a metabolizers reference oh-mdz pharmacokinetic erythromycin difference metabolism status 1´‑ allelic metabolizer model erythromycin breath test result therapy statin cyp 3a genotypes level association clearance response cholesterol polymorphism cyp 3a genotype group concentration 1´‑ oh-mdz reduction simvastatin therapy van schaik rh cyp 3a snp pharmacol cytochrome cancer patients table article measurement mdzdadj bolus administration <0.001 parameter pharmacogenomic figure expression ldlc levels influence population probe variant t-variant administration future cluster research analysis point t-variant allele carriers science cyp 3a expressers mg /l liver breath hepatic pharmacogenetic lipid